Group VIA Calcium-independent Phospholipase A2 Mediates Endothelial Cell S Phase Progression.
Arachidonic acid and its metabolites have been previously implicated in the regulation of endothelial cell proliferation. Arachidonic acid may be liberated from cellular phospholipids by the action of group VIA calcium-independent phospholipase A(2) (iPLA(2)-VIA). Consequently, we tested the hypothesis that iPLA(2)-VIA activity is linked to the regulation of endothelial cell proliferation. Inhibition of iPLA(2) activity by bromoenol lactone (BEL) was sufficient to entirely block endothelial cell growth. BEL dose-dependently inhibited endothelial cell DNA synthesis in a manner that was reversed upon the exogenous addition of arachidonic acid. DNA synthesis was inhibited by the S-isomer and not by the R-isomer of BEL, demonstrating that endothelial cell proliferation is mediated specifically by iPLA2-VIA. iPLA(2)-VIA activity was critical to the progression of endothelial cells through S phase and is required for the expression of the cyclin A/cdk2 complex. Thus, inhibition of iPLA(2)-VIA blocks S phase progression and results in exit from the cell cycle. Inhibition of iPLA(2)-VIA-mediated endothelial cell proliferation is sufficient to block angiogenic tubule formation in co-culture assays. Consequently, iPLA(2)-VIA is a novel regulator of endothelial cell S phase progression, cell cycle residence, and angiogenesis.[1]References
- Group VIA Calcium-independent Phospholipase A2 Mediates Endothelial Cell S Phase Progression. Herbert, S.P., Walker, J.H. J. Biol. Chem. (2006) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg